XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 16 - Stockholders' Equity (Tables)
12 Months Ended
Mar. 31, 2024
Notes Tables  
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
  

Fiscal years ended March 31,

 
  

2024

  

2023

 

Stock options

 $40  $32 

Restricted stock and stock awards

  4,563   4,656 

Employee stock purchase plan

  49   41 

Total stock-based compensation expense

 $4,652  $4,729 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Fiscal years ended March 31,

 
  

2024

  

2023

 

Cost of revenues

 $293  $283 

Research and development

  627   865 

Selling, general and administrative

  3,732   3,581 

Total

 $4,652  $4,729 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Options / Shares

  

Weighted-Average Exercise Price

  

Weighted-Average Remaining Contractual Term

  

Aggregate Intrinsic Value (thousands)

 

Outstanding at March 31, 2023

  81,205  $16.92         

Granted

              

Exercised

              

Canceled/forfeited

  (44,999)  24.95         

Outstanding at March 31, 2024

  36,206  $6.94   6.2  $238 

Exercisable at March 31, 2024

  25,924  $7.34   5.4  $160 

Fully vested and expected to vest at March 31, 2024

  36,107  $6.94   6.2  $237 
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
     
     

Expected volatility

  71.4%

Risk-free interest rate

  3.1%

Expected life (years)

  6.1 

Dividend yield

  None 
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
  

Shares

  

Weighted Average Grant Date Fair Value

  

Intrinsic Aggregate Value (thousands)

 

Outstanding at March 31, 2023

  1,477,999  $6.89     

Granted

  735,175   6.57     

Vested

  (735,267)  6.83     

Forfeited

  (52,253)  7.31     

Outstanding at March 31, 2024

  1,425,654  $6.74  $19,261